Feugiat nulla facilisis at vero eros et curt accumsan et iusto odio dignissim qui blandit praesent luptatum zzril.
+ (123) 1800-453-1546

Related Posts

Clinical and Basic Science Approaches to Phage: “Bringing Phage to Bedside: Implementing a Phage Clinical Trial” – Brian Chow, MD & “Looking for Validation: Assessing ICP1 Mutant Fitness After Tn-seq” – Tufts Molecular Microbiology PhD Candidate Elizabeth Tan

Date: November 16, 2023
Time: 12:00 pm - 1:00 pm
Levy CIMAR Science Lunch

Please join us for our November Levy CIMAR Science Seminar, which will dive into recent bacteriophage work from both the clinical and basic science perspectives. We will hear from two speakers this month: CIMAR’s own Brian Chow, MD, an Attending Physician and Director of the Infectious Diseases Fellowship Program at Tufts Medical Center, and Elizabeth Tan, a PhD candidate studying cholera bacteriophage in the laboratory of CIMAR’s Andrew Camilli, PhD. The talks will take place on Thursday, November 16th, in Behrakis Auditorium (1st floor, Jaharis Building, 150 Harrison Ave.) and by Zoom (details to come).

Dr. Chow will present on “Bringing Phage to Bedside: Implementing a Phage Clinical Trial.” His work at Tufts Medical Center involves clinical trials which advance novel therapeutics and vaccines to FDA approval, and he is interested in trials involving bacteriophage as adjunctive therapy for drug resistant infections. (Learn more about Dr. Chow here.)

Ms. Tan will present on “Looking for Validation: Assessing ICP1 Mutant Fitness After Tn-seq.” Her research in the Camilli Lab looks at how the cholera phage ICP1 completes its viral lifecycle under different host contexts using high throughput sequencing to systematically study phage genes. (Learn more about Ms. Tan here.)